{"id":6505,"date":"2024-05-24T10:07:50","date_gmt":"2024-05-24T08:07:50","guid":{"rendered":"http:\/\/jcet.eu\/new\/?p=6505"},"modified":"2024-07-19T13:38:12","modified_gmt":"2024-07-19T11:38:12","slug":"polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek","status":"publish","type":"post","link":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/","title":{"rendered":"POLONEZ BIS-3 &#8211; wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\" id=\"tw-target-text\"><strong>Ju\u017c oficjalnie pragniemy powita\u0107 now\u0105 cz\u0142onkinie zespo\u0142u JCET, Pani\u0105 dr hab. Anet\u0119 Radziwon-Balicka, kt\u00f3ra b\u0119dzie realizowa\u0107 projekt pt.: <em>&#8222;Wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na szlak Syk w subpopulacjach p\u0142ytek krwi opartych na eNOS i na integralno\u015bci bariery \u015br\u00f3db\u0142onka&#8221;<\/em>, w ramach finansowania z programu POLONEZ BIS-3.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Program POLONEZ BIS jest wsp\u00f3\u0142finansowany przez Komisj\u0119 Europejsk\u0105 i Narodowe Centrum Nauki w ramach presti\u017cowego grantu Marie Sk\u0142odowska-Curie COFUND. W trzech konkursach, zrekrutowano ponad 120 naukowc\u00f3w z ca\u0142ego \u015bwiata, kt\u00f3rzy przyjad\u0105 do Polski na 24 miesi\u0105ce, aby prowadzi\u0107 tu badania podstawowe w wybranych przez siebie instytucjach.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png\"><img loading=\"lazy\" decoding=\"async\" width=\"810\" height=\"450\" src=\"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png\" alt=\"\" class=\"wp-image-6508\" srcset=\"https:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png 810w, https:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2-300x167.png 300w, https:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2-768x427.png 768w\" sizes=\"auto, (max-width: 810px) 100vw, 810px\" \/><\/a><\/figure>\n\n\n\n<!--more-->\n\n\n\n<p class=\"wp-block-paragraph\">Lepsze zrozumienie patogenezy powik\u0142a\u0144 sercowo-naczyniowych u pacjent\u00f3w leczonych inhibitorami ma\u0142ocz\u0105steczkowymi jest pilnie potrzebne w celu poprawy bezpiecze\u0144stwa terapii przeciwnowotworowej. Naszym celem jest scharakteryzowanie mo\u017cliwego wp\u0142ywu p\u0142ytek krwi na kom\u00f3rki \u015br\u00f3db\u0142onka oraz zbadanie wp\u0142ywu inhibitor\u00f3w drobnocz\u0105steczkowych na funkcjonalno\u015b\u0107 \u015br\u00f3db\u0142onka. Przewidujemy, \u017ce ten projekt badawczy przyniesie now\u0105 wiedz\u0119 na temat p\u0142ytek krwi i ich funkcjonalnego wp\u0142ywu na integralno\u015b\u0107 bariery \u015br\u00f3db\u0142onkowej. Ponadto, badanie kliniczne b\u0119dzie mia\u0142o na celu sprawdzenie, czy inhibitory ma\u0142ocz\u0105steczkowe mog\u0105 mie\u0107 r\u00f3\u017cny wp\u0142yw na p\u0142ytki krwi i integralno\u015b\u0107 bariery \u015br\u00f3db\u0142onkowej u pacjent\u00f3w z przewlek\u0142\u0105 bia\u0142aczk\u0105 szpikow\u0105 nieleczonych i leczonych inhibitorami ma\u0142ocz\u0105steczkowymi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ju\u017c oficjalnie pragniemy powita\u0107 now\u0105 cz\u0142onkinie zespo\u0142u JCET, Pani\u0105 dr hab. Anet\u0119 Radziwon-Balicka, kt\u00f3ra b\u0119dzie realizowa\u0107 projekt pt.: &#8222;Wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na szlak Syk w subpopulacjach p\u0142ytek krwi opartych na eNOS i na integralno\u015bci bariery \u015br\u00f3db\u0142onka&#8221;, w ramach finansowania<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6505","post","type-post","status-publish","format-standard","hentry","category-viaria"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>POLONEZ BIS-3 - wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek &#187; JCET<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/\" \/>\n<meta property=\"og:locale\" content=\"pl_PL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"POLONEZ BIS-3 - wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek &#187; JCET\" \/>\n<meta property=\"og:description\" content=\"Ju\u017c oficjalnie pragniemy powita\u0107 now\u0105 cz\u0142onkinie zespo\u0142u JCET, Pani\u0105 dr hab. Anet\u0119 Radziwon-Balicka, kt\u00f3ra b\u0119dzie realizowa\u0107 projekt pt.: &#8222;Wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na szlak Syk w subpopulacjach p\u0142ytek krwi opartych na eNOS i na integralno\u015bci bariery \u015br\u00f3db\u0142onka&#8221;, w ramach finansowania\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/\" \/>\n<meta property=\"og:site_name\" content=\"JCET\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/jcet.eu\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-24T08:07:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-19T11:38:12+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png\" \/>\n<meta name=\"author\" content=\"Agnieszka Gudek\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisane przez\" \/>\n\t<meta name=\"twitter:data1\" content=\"Agnieszka Gudek\" \/>\n\t<meta name=\"twitter:label2\" content=\"Szacowany czas czytania\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/\"},\"author\":{\"name\":\"Agnieszka Gudek\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/person\\\/7481d842210493c661fbf7ab2c7584e7\"},\"headline\":\"POLONEZ BIS-3 &#8211; wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek\",\"datePublished\":\"2024-05-24T08:07:50+00:00\",\"dateModified\":\"2024-07-19T11:38:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/\"},\"wordCount\":247,\"publisher\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Untitled-design-2-2.png\",\"articleSection\":[\"Varia\"],\"inLanguage\":\"pl-PL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/\",\"name\":\"POLONEZ BIS-3 - wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek &#187; JCET\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Untitled-design-2-2.png\",\"datePublished\":\"2024-05-24T08:07:50+00:00\",\"dateModified\":\"2024-07-19T11:38:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/#breadcrumb\"},\"inLanguage\":\"pl-PL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/#primaryimage\",\"url\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Untitled-design-2-2.png\",\"contentUrl\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/Untitled-design-2-2.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/2024\\\/05\\\/24\\\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Strona g\u0142\u00f3wna\",\"item\":\"https:\\\/\\\/jcet.eu\\\/new\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"POLONEZ BIS-3 &#8211; wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na&nbsp;subpopulacje p\u0142ytek krwi i&nbsp;\u015br\u00f3db\u0142onek\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#website\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/\",\"name\":\"JCET\",\"description\":\"Centrum doskona\u0142o\u015bci w farmakologii \u015br\u00f3db\u0142onka.\",\"publisher\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/jcet.eu\\\/new\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pl-PL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#organization\",\"name\":\"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pl-PL\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/JCET-logo.png\",\"contentUrl\":\"http:\\\/\\\/jcet.eu\\\/new\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/JCET-logo.png\",\"width\":715,\"height\":401,\"caption\":\"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)\"},\"image\":{\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/jcet.eu\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/jcet.eu\\\/new\\\/#\\\/schema\\\/person\\\/7481d842210493c661fbf7ab2c7584e7\",\"name\":\"Agnieszka Gudek\",\"url\":\"https:\\\/\\\/jcet.eu\\\/new\\\/author\\\/agag2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"POLONEZ BIS-3 - wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek &#187; JCET","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/","og_locale":"pl_PL","og_type":"article","og_title":"POLONEZ BIS-3 - wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek &#187; JCET","og_description":"Ju\u017c oficjalnie pragniemy powita\u0107 now\u0105 cz\u0142onkinie zespo\u0142u JCET, Pani\u0105 dr hab. Anet\u0119 Radziwon-Balicka, kt\u00f3ra b\u0119dzie realizowa\u0107 projekt pt.: &#8222;Wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na szlak Syk w subpopulacjach p\u0142ytek krwi opartych na eNOS i na integralno\u015bci bariery \u015br\u00f3db\u0142onka&#8221;, w ramach finansowania","og_url":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/","og_site_name":"JCET","article_publisher":"https:\/\/www.facebook.com\/jcet.eu\/","article_published_time":"2024-05-24T08:07:50+00:00","article_modified_time":"2024-07-19T11:38:12+00:00","og_image":[{"url":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png","type":"","width":"","height":""}],"author":"Agnieszka Gudek","twitter_card":"summary_large_image","twitter_misc":{"Napisane przez":"Agnieszka Gudek","Szacowany czas czytania":"2 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/#article","isPartOf":{"@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/"},"author":{"name":"Agnieszka Gudek","@id":"https:\/\/jcet.eu\/new\/#\/schema\/person\/7481d842210493c661fbf7ab2c7584e7"},"headline":"POLONEZ BIS-3 &#8211; wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek","datePublished":"2024-05-24T08:07:50+00:00","dateModified":"2024-07-19T11:38:12+00:00","mainEntityOfPage":{"@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/"},"wordCount":247,"publisher":{"@id":"https:\/\/jcet.eu\/new\/#organization"},"image":{"@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png","articleSection":["Varia"],"inLanguage":"pl-PL"},{"@type":"WebPage","@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/","url":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/","name":"POLONEZ BIS-3 - wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na subpopulacje p\u0142ytek krwi i \u015br\u00f3db\u0142onek &#187; JCET","isPartOf":{"@id":"https:\/\/jcet.eu\/new\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/#primaryimage"},"image":{"@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/#primaryimage"},"thumbnailUrl":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png","datePublished":"2024-05-24T08:07:50+00:00","dateModified":"2024-07-19T11:38:12+00:00","breadcrumb":{"@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/#breadcrumb"},"inLanguage":"pl-PL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/"]}]},{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/#primaryimage","url":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png","contentUrl":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2024\/05\/Untitled-design-2-2.png"},{"@type":"BreadcrumbList","@id":"https:\/\/jcet.eu\/new\/2024\/05\/24\/polonez-bis-3-wplyw-inhibitorow-kinazy-tyrozynowej-na-srodblonek\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Strona g\u0142\u00f3wna","item":"https:\/\/jcet.eu\/new\/"},{"@type":"ListItem","position":2,"name":"POLONEZ BIS-3 &#8211; wp\u0142yw inhibitor\u00f3w kinazy tyrozynowej na&nbsp;subpopulacje p\u0142ytek krwi i&nbsp;\u015br\u00f3db\u0142onek"}]},{"@type":"WebSite","@id":"https:\/\/jcet.eu\/new\/#website","url":"https:\/\/jcet.eu\/new\/","name":"JCET","description":"Centrum doskona\u0142o\u015bci w farmakologii \u015br\u00f3db\u0142onka.","publisher":{"@id":"https:\/\/jcet.eu\/new\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jcet.eu\/new\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pl-PL"},{"@type":"Organization","@id":"https:\/\/jcet.eu\/new\/#organization","name":"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)","url":"https:\/\/jcet.eu\/new\/","logo":{"@type":"ImageObject","inLanguage":"pl-PL","@id":"https:\/\/jcet.eu\/new\/#\/schema\/logo\/image\/","url":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2022\/06\/JCET-logo.png","contentUrl":"http:\/\/jcet.eu\/new\/wp-content\/uploads\/2022\/06\/JCET-logo.png","width":715,"height":401,"caption":"Jagiello\u0144skie Centrum Rozwoju Lek\u00f3w (JCET)"},"image":{"@id":"https:\/\/jcet.eu\/new\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/jcet.eu\/"]},{"@type":"Person","@id":"https:\/\/jcet.eu\/new\/#\/schema\/person\/7481d842210493c661fbf7ab2c7584e7","name":"Agnieszka Gudek","url":"https:\/\/jcet.eu\/new\/author\/agag2\/"}]}},"_links":{"self":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts\/6505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/comments?post=6505"}],"version-history":[{"count":2,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts\/6505\/revisions"}],"predecessor-version":[{"id":6626,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/posts\/6505\/revisions\/6626"}],"wp:attachment":[{"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/media?parent=6505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/categories?post=6505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jcet.eu\/new\/wp-json\/wp\/v2\/tags?post=6505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}